Abstract 4359604: Model-Based Evaluation of LDL-C Lowering for Laroprovstat (AZD0780), An Oral Small Molecule PCSK9 Inhibitor, and Rosuvastatin
Year: 2025
Type: conference-abstract
Source: Circulation
Authors: Hongtao Yu, April Barbour, Rick Vega, Michael McCarthy, Per Johanson, Jaya Rosenmeier
Institutions: AstraZeneca (United States), AstraZeneca (Sweden)
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415794332
Cites:
Cited by:
Related to: